β-carotene regulates cancer stemness in colon cancer in vivo and in vitro
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Colorectal cancer (CRC) is the third most common cancer worldwide and has a high recurrence rate, which is associated with cancer stem cells (CSCs). β-carotene (BC) possesses antioxidant activity and several anticancer mechanisms. However, no investigation has examined its effect on colon cancer stemness. MATERIALS/METHODS: CD133+CD44+ HCT116 and CD133+CD44+ HT-29 cells were isolated and analyzed their self-renewal capacity by clonogenic and sphere formation assays. Expressions of several CSCs markers and Wnt/β-catenin signaling were examined. In addition, CD133+CD44+ HCT116 cells were subcutaneously injected in xenograft mice and analyzed the effect of BC on tumor formation, tumor volume, and CSCs markers in tumors. RESULTS: BC inhibited self-renewal capacity and CSC markers, including CD44, CD133, ALDH1A1, NOTCH1, Sox2, and β-catenin in vitro. The effects of BC on CSC markers were confirmed in primary cells isolated from human CRC tumors. BC supplementation decreased the number and size of tumors and delayed the tumor-onset time in xenograft mice injected with CD133+CD44+ HCT116 cells. The inhibitory effect of BC on CSC markers and the Wnt/β-catenin signaling pathway in tumors was confirmed in vivo as well. CONCLUSIONS: These results suggest that BC may be a potential therapeutic agent for colon cancer by targeting colon CSCs.
Abstract
BACKGROUND/OBJECTIVES: Colorectal cancer (CRC) is the third most common cancer worldwide and has a high recurrence rate, which is associated with cancer stem cells (CSCs). β-carotene (BC) possesses antioxidant activity and several anticancer mechanisms. However, no investigation has examined its effect on colon cancer stemness. MATERIALS/METHODS: CD133+CD44+ HCT116 and CD133+CD44+ HT-29 cells were isolated and analyzed their self-renewal capacity by clonogenic and sphere formation assays. Expressions of several CSCs markers and Wnt/β-catenin signaling were examined. In addition, CD133+CD44+ HCT116 cells were subcutaneously injected in xenograft mice and analyzed the effect of BC on tumor formation, tumor volume, and CSCs markers in tumors. RESULTS: BC inhibited self-renewal capacity and CSC markers, including CD44, CD133, ALDH1A1, NOTCH1, Sox2, and β-catenin in vitro. The effects of BC on CSC markers were confirmed in primary cells isolated from human CRC tumors. BC supplementation decreased the number and size of tumors and delayed the tumor-onset time in xenograft mice injected with CD133+CD44+ HCT116 cells. The inhibitory effect of BC on CSC markers and the Wnt/β-catenin signaling pathway in tumors was confirmed in vivo as well. CONCLUSIONS: These results suggest that BC may be a potential therapeutic agent for colon cancer by targeting colon CSCs.
참고문헌 (40)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Clarke MF, "Cancer stem cells--perspectives on current status and future directions : AACR workshop on cancer stem cells", Cancer Res, 66, pp.9339~9344 (2006)
- Lobo NA, "The biology of cancer stem cells", Annu Rev Cell Dev Biol, 23, pp.675~699 (2007)
- Cherciu I, "Stem cells, colorectal cancer and cancer stem cell markers correlations", Curr Health Sci J, 40, pp.153~161 (2014)
- Sikandar SS, "NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer", Cancer Res, 70, pp.1469~1478 (2010)
- Lundberg IV, "SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer", BMC Cancer, 16, pp.471~ (2016)
- Roy S, "Signaling in colon cancer stem cells", J Mol Signal, 7, pp.11~ (2012)
- Brabletz S, "Gastrointestinal stem cells in development and cancer", J Pathol, 217, pp.307~317 (2009)
- Comstock GW, "The risk of developing lung cancer associated with antioxidants in the blood : ascorbic acids, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity", Am J Epidemiol, 168, pp.831~840 (2008)
- Lin J, "Vitamins C and E and beta carotene supplementation and cancer risk : a randomized controlled trial", J Natl Cancer Inst, 101, pp.14~23 (2009)
- Temple NJ, "Protective effect of beta-carotene against colon tumors in mice", J Natl Cancer Inst, 78, pp.1211~1214 (1987)
- Pham DN, "β, β-carotene 15, 15′-monooxygenase and its substrate β-carotene modulate migration and invasion in colorectal carcinoma cells", Am J Clin Nutr, 98, pp.413~422 (2013)
- Lim JY, "B-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness", Biochem Biophys Res Commun, 450, pp.1475~1480 (2014)
- Lee HA, "Effect of β-carotene on cancer cell stemness and differentiation in SK-N-BE(2)C neuroblastoma cells", Oncol Rep, 30, pp.1869~1877 (2013)
- Min SJ, "Sasa quelpaertensis leaf extract inhibits colon cancer by regulating cancer cell stemness in vitro and in vivo", Int J Mol Sci, 16, pp.9976~9997 (2015)
- Kim Y, "Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity", Cancer Res, 69, pp.9271~9280 (2009)
- Kim YS, "β-Carotene 15, 15′-oxygenase inhibits cancer cell stemness and metastasis by regulating differentiation-related miRNAs in human neuroblastoma", J Nutr Biochem, 69, pp.31~43 (2019)
- Kim E, "Phyllodulcin, a natural functional sweetener, improves diabetic metabolic changes by regulating hepatic lipogenesis, inflammation, oxidative stress, fibrosis, and gluconeogenesis in db", db mice, 2018, pp.42, 1~11
- Puck TT, "Action of X-rays on mammalian cells", J Exp Med, 103, pp.653~666 (1956)
- Daeun Kim, "Effects of b-carotene on Expression of Selected MicroRNAs, Histone Acetylation, and DNA Methylation in Colon Cancer Stem Cells", 대한암예방학회지, 24(4), pp.224~232 (2019), 대한암예방학회
- O'Brien CA, "A human colon cancer cell capable of initiating tumour growth in immunodeficient mice", Nature, 445, pp.106~110 (2007)
- Ricci-Vitiani L, "Identification and expansion of human colon-cancer-initiating cells", Nature, 445, pp.111~115 (2007)
- Ong CW, "CD133 expression predicts for non-response to chemotherapy in colorectal cancer", Mod Pathol, 23, pp.450~457 (2010)
- Horst D, "The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer", J Pathol, 219, pp.427~434 (2009)
- Afify A, "Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion", Exp Mol Pathol, 86, pp.95~100 (2009)
- Ju SY, "Maintenance of the stemness in CD44+ HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression", Stem Cell Res(Amst), 12, pp.86~100 (2014)
- Haraguchi N, "CD133+CD44+ population efficiently enriches colon cancer initiating cells", Ann Surg Oncol, 15, pp.2927~2933 (2008)
- Tomita H, "Aldehyde dehydrogenase 1A1 in stem cells and cancer", Oncotarget, 7, pp.11018~11032 (2016)
- Kanwar SS, "The Wnt", beta-catenin pathway regulates growth and maintenance of colonospheres, 2010, pp.9, 212~
- Li Y, "Sulforaphane, a dietary component of broccoli", broccoli sprouts, inhibits breast cancer stem cells, 2010, pp.16, 2580~2590
- Ryu MJ, "Natural derivatives of curcumin attenuate the Wnt", beta-catenin pathway through down-regulation of the transcriptional coactivator p300, 2008, pp.377, 1304~1308
- van Staveren WC, "Human cancer cell lines : experimental models for cancer cells in situ? For cancer stem cells?", Biochim Biophys Acta, 1795, pp.92~103 (2009)
- Reagan-Shaw S, "Dose translation from animal to human studies revisited", FASEB J, 22, pp.659~661 (2008)
- Mech-Nowak A, "Content of carotenoids in roots of seventeen cultivars of Daucus carota L", Acta Biochim Pol, 59, pp.139~141 (2012)
- Liu C, "Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets", Carcinogenesis, 21, pp.2245~2253 (2000)
- Yang CM, "Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice", Mol Nutr Food Res, 55, pp.606~612 (2011)
- Männistö S, "Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies", Am J Epidemiol, 165, pp.246~255 (2007)
- Omenn GS, "Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial", J Natl Cancer Inst, 88, pp.1550~1559 (1996)
- Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, "The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers", N Engl J Med, 330, pp.1029~1035 (1994)
- Yan M, "Differentiation therapy : a promising strategy for cancer treatment", Chin J Cancer, 35, pp.3~ (2016)
